These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7506183)

  • 1. Toxicity of nonsteroidal anti-inflammatory drugs. An overview of the epidemiological evidence.
    Carson JL; Willett LR
    Drugs; 1993; 46 Suppl 1():243-8. PubMed ID: 7506183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus.
    Bjorkman D
    Am J Med; 1998 Nov; 105(5A):17S-21S. PubMed ID: 9855171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential renal, haematological and allergic adverse effects associated with nonsteroidal anti-inflammatory drugs.
    Kenny GN
    Drugs; 1992; 44 Suppl 5():31-6; discussion 37. PubMed ID: 1284559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacoeconomics of nonsteroidal anti-inflammatory drugs (NSAIDs).
    Wynne HA; Campbell M
    Pharmacoeconomics; 1993 Feb; 3(2):107-23. PubMed ID: 10146960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 1994 Merck Frosst Award. Mechanisms of nonsteroidal anti-inflammatory drug (NSAID) induced gastrointestinal damage--potential for development of gastrointestinal tract safe NSAIDs.
    Wallace JL
    Can J Physiol Pharmacol; 1994 Dec; 72(12):1493-8. PubMed ID: 7736340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-effects of non-steroidal anti-inflammatory drugs.
    Henry DA
    Baillieres Clin Rheumatol; 1988 Aug; 2(2):425-54. PubMed ID: 3066501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actions and toxicity of nonsteroidal anti-inflammatory drugs.
    Simon LS
    Curr Opin Rheumatol; 1995 May; 7(3):159-66. PubMed ID: 7612406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity of nonsteroidal anti-inflammatory drugs.
    Rabinovitz M; Van Thiel DH
    Am J Gastroenterol; 1992 Dec; 87(12):1696-704. PubMed ID: 1449128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal effects of NSAIDs. Difficulties in detection and management.
    Pearson SP; Kelberman I
    Postgrad Med; 1996 Nov; 100(5):131-2, 135-6, 141-3. PubMed ID: 8917329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
    Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
    Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NSAIDs, gastrointestinal injury, and cytoprotection.
    Scheiman JM
    Gastroenterol Clin North Am; 1996 Jun; 25(2):279-98. PubMed ID: 9229573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs.
    Knodel LC; Roush MK; Barton TL
    Clin Podiatr Med Surg; 1992 Apr; 9(2):301-25. PubMed ID: 1586906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant use of low-dose methotrexate and NSAIDs and the risk of serious adverse events among patients with rheumatoid arthritis.
    Svanström H; Lund M; Melbye M; Pasternak B
    Pharmacoepidemiol Drug Saf; 2018 Aug; 27(8):885-893. PubMed ID: 29797447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The problems and pitfalls of NSAID therapy in the elderly (Part I).
    Johnson AG; Day RO
    Drugs Aging; 1991 Mar; 1(2):130-43. PubMed ID: 1794009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between concomitant use of several systemic NSAIDs and an excess risk of adverse drug reaction. A case/non-case study from the French Pharmacovigilance system database.
    Clinard F; Sgro C; Bardou M; Hillon P; Dumas M; Kreft-Jais C; Escousse A; Bonithon-Kopp C
    Eur J Clin Pharmacol; 2004 Jun; 60(4):279-83. PubMed ID: 15103437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of prescribing nonsteroidal anti-inflammatory drugs in oral health care--a review.
    Nagi R; Yashoda Devi BK; Rakesh N; Reddy SS; Patil DJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Mar; 119(3):264-71. PubMed ID: 25617120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 selective inhibitors in the treatment of osteoarthritis.
    Laine L; White WB; Rostom A; Hochberg M
    Semin Arthritis Rheum; 2008 Dec; 38(3):165-87. PubMed ID: 18177922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can nonsteroidal anti-inflammatory drugs favourably affect the alimentary canal?
    Cichoz-Lach H; Celiński K
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):399-402. PubMed ID: 12898869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide-releasing NSAIDs: a review of their current status.
    Fiorucci S; Antonelli E; Burgaud JL; Morelli A
    Drug Saf; 2001; 24(11):801-11. PubMed ID: 11665868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.